Michael Feld is EVP & President, Life Sciences of BECTON DICKINSON & CO. Currently has a direct ownership of 8,245 shares of BDX, which is worth approximately $1.59 Million. The most recent transaction as insider was on Oct 27, 2025, when has been sold 57 shares (Common Stock) at a price of $186.01 per share, resulting in proceeds of $10,602. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.25K
10.28% 3M change
24.23% 12M change
Total Value Held $1.59 Million

Michael Feld Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 27 2025
SELL
Open market or private sale
$10,602 $186.01 p/Share
57 Reduced 0.69%
8,245 Common Stock
Sep 26 2025
SELL
Open market or private sale
$10,499 $181.03 p/Share
58 Reduced 0.69%
8,302 Common Stock
Aug 22 2025
SELL
Open market or private sale
$11,285 $197.99 p/Share
57 Reduced 0.68%
8,360 Common Stock
Aug 20 2025
SELL
Payment of exercise price or tax liability
-
773 Reduced 8.41%
8,417 Common Stock
Nov 26 2024
BUY
Grant, award, or other acquisition
-
2,553 Added 21.74%
9,190 Common Stock
Aug 20 2024
BUY
Grant, award, or other acquisition
-
6,637 Added 50.0%
6,637 Common Stock
MF

Michael Feld

EVP & President, Life Sciences
Franklin Lakes, NJ

Track Institutional and Insider Activities on BDX

Follow BECTON DICKINSON & CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDX shares.

Notify only if

Insider Trading

Get notified when an Becton Dickinson & CO insider buys or sells BDX shares.

Notify only if

News

Receive news related to BECTON DICKINSON & CO

Track Activities on BDX